Parents' reported preference scores for childhood atopic dermatitis disease states

BMC Pediatrics

Volumn 4, Issue , 2004, Pages

  Friedman, Joëlle Y ^a   Reed, Shelby D ^a   Weinfurt, Kevin P ^a   Kahler, Kristijan H ^b   Walter, Emmanuel B ^c   Schulman, Kevin A ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CHILD PARENT RELATION; CHILDHOOD DISEASE; CONTROLLED STUDY; DECISION MAKING; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HUMAN; HYPOTHESIS; INFORMATION PROCESSING; MALE; PARENTAL BEHAVIOR; QUALITY OF LIFE; SCORING SYSTEM; SPECTACLES; VISUAL ANALOG SCALE; ADOLESCENT; CHILD; CLASSIFICATION; HEALTH STATUS; INFANT; PARENT; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; HEALTH STATUS; HUMANS; INFANT; MALE; PARENTS; POPULATION SURVEILLANCE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 12944275357     PISSN: 14712431     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2431-4-21     Document Type: Article

References (21)

1. Schultz Larsen F, Hanifin JM: Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am 2002, 22:1-24.
2. Taylor B, Wadsworth J, Wadsworth M, Peckham C: Changes in the reported prevalence of childhood eczema since the 1939-45 war. Lancet 1984, 2:1255-1257.
3. Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, Lebwohl M, Stevens SR, Whitaker-Worth DL, Cheng JW, Tong KB: Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol 2002, 46:361-370.
4. Lapidus CS, Kerr PE: Social impact of atopic dermatitis. Med Health R I 2001, 84:294-295.
5. Lawson V, Lewis-Jones MS, Finlay AY, Reid P, Owens RG: The family impact of childhood atopic dermatitis: the dermatitis family impact questionnaire. Br J Dermatol 1998, 138:107-113.
6. Long CC, Funnell CM, Collard R, Finlay AY: What do Members of the National-Eczema-Society Really Want. Clin Exp Dermatol 1993, 18:516-522.
7. Lewis-Jones MS, Finlay AY, Dykes PJ: The infants' dermatitis quality of life index. Br J Dermatol 2001, 144: 04-110.
8. Reid P, Lewisjones MS: Sleep Difficulties and Their Management in Preschoolers with Atopic Eczema. Clin Exp Dermatol 1995, 20:38-41.
9. Fivenson D, Arnold RJ, Kaniecki DJ, Cohen JL, Frech F, Finlay AY: The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization. J Manag Care Pharm 2002, 8:333-342.
10. Ben Gashir MA, Seed PT, Hay RJ: Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol 2004, 150:284-290.
11. Whalley D, McKenna SP, Dewar AL, Erdman RA, Kohlmann T, Niero M, Cook SA, Crickx B, Herdman MJ, Frech F, Van Assche D: A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br J Dermatol 2004, 150:274-283.
12. Drake L, Prendergast M, Maher R, Breneman D, Korman N, Satoi Y, Beusterien KM, Lawrence I: The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol 2001, 44:S65-S72.
13. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M: Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol 1999, 141:1067-1075.
14. Zug KA, Littenberg B, Baughman RD, Kneeland T, Nease RF, Sumner W, Oconnor GT, Jones R, Morrison E, Cimis R: Assessing the Preferences of Patients with Psoriasis - A Quantitative, Utility Approach. Arch Dermatol 1995, 131:561-568.
15. Theunissen NCM, Vogels AGC, Veripps GH, Koopman HM, Kamphuis RP, vanZoelen CWM, Feekes M, VerlooveVanhorick SP, Wit JM: The proxy problem: Parents and children's views on children's health-related quality of life. Qual Life Res 1997, 6:39-39.
16. Barbier N, Paul C, Luger T, Allen R, De Prost Y, Papp K, Eichenfield LF, Cherill R, Hanifin J: Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme. Br J Dermatol 2004, 150:96-102.
17. Cost-Effectiveness in Health and Medicine Edited by: GoldMR, SiegelJE, RussellLB and WeinsteinMC. New York, Oxford University Press; 1996.
18. Yabroff KR, Linas BP, Schulman K: Evaluation of quality of life for diverse patient populations. Breast Cancer Res Treat 1996, 40:87-104.
19. Dolan P: The effect of experience of illness on health state valuations. J Clin Epidemiol 1996, 49:551-564.
20. Gabriel SE, Kneeland TS, Melton LJ,III, Moncur MM, Ettinger B, Tosteson AN: Health-related quality of life in economic evaluations for osteoporosis: whose values should we use? Med Decis Making 1999, 19:141-148.
21. Badia X, Herdman M, Kind P: The influence of ill-health experience on the valuation of health. Pharmacoeconomics 1998, 13:687-696.